TGA releases vaccine-related myocarditis severity details

Matt Woodley

8/04/2022 5:40:20 PM

Fewer than 1% of all likely myocarditis or pericarditis cases linked to mRNA vaccines in Australia have been treated in intensive care.

Person receiving ECG.
No one has died as a result of vaccine-related myocarditis or pericarditis in Australia.

Only nine people with likely myocarditis or pericarditis associated with COVID-19 vaccination have been treated in Australian intensive care units, according to the Therapeutic Goods Administration (TGA).
The number represents less than 1% of all likely cases, while most of the approximately 700 patients admitted to hospital were reportedly discharged within four days.
Overall, 1399 people have been identified as having vaccine-linked suspected myocarditis since the COVID-19 vaccine rollout began, equivalent to three cases per 100,000 doses (0.003%). It also means that only 1.6 people have been hospitalised for every 100,000 doses, while for every five million doses, one person has ended up in intensive care.
No one has died as a result of vaccine-related myocarditis or pericarditis in Australia.
Conversely, at the time of publication 6526 people had died due to COVID-19 in Australia, at a rate of 130 deaths per 100,000 known cases.
The local experience with mRNA vaccines is similar to that of other comparable countries, such as the US, insofar as the highest rates of suspected myocarditis and pericarditis hospitalisations and cases have occurred in males under 30 years of age.
According to the TGA, in the majority of cases symptoms had resolved by the time patients were discharged and the most common treatment for these individuals was nonsteroidal anti-inflammatory drugs, such as ibuprofen.
‘Evidence from a US surveillance survey of patients who had myocarditis following vaccination indicates that most patients fully recover without lasting impacts on their quality of life or ability to work,’ the most recent TGA COVID-19 vaccine safety report states.
‘The survey, which was conducted three months after the initial myocarditis diagnosis, involved mostly men under 30 years after their second vaccine dose.
‘There were no deaths from myocarditis reported in these patients.’
The highest rates of vaccine-linked myocarditis in Australia are still among boys aged 12–17 who have received the Moderna vaccine (20 cases per 100,000 second doses), closely followed by men aged 18–29 who received the same vaccine (17.8 cases per 100,000 second doses).
To date, the youngest case classified as ‘likely myocarditis’ was nine years old.
For the first time, the TGA has confirmed receiving a small number of reports of suspected myocarditis and/or pericarditis in people who have received the Novavax vaccine.
However, after assessing these cases against a set of internationally accepted criteria, none were deemed likely to represent myocarditis, while only four were likely to represent pericarditis.
Moreover, the TGA has not identified a safety signal that would indicate an association between Novavax and either condition.
The most commonly reported reactions to Novavax, according to AusVaxSafety survey, are fatigue, injection-site reactions and headache, which are ‘expected side effects’ that were also seen in clinical trials.
There have been 424 reports of suspected adverse events from about 97,800 Novavax doses administered in Australia up until 3 April, the TGA said. The most commonly reported reactions include headache, chest pain, paraesthesia (skin tingling), fatigue and dizziness.
Log in below to join the conversation.

COVID-19 Moderna mRNA myocarditis Novavax pericarditis Pfizer vaccination

newsGP weekly poll What areas of healthcare were you hoping would get more funding in this year's Federal Budget?

newsGP weekly poll What areas of healthcare were you hoping would get more funding in this year's Federal Budget?



Login to comment

Dr San   13/04/2022 6:30:30 AM

Would be interesting to also compare other causes of death related to Covid vaccines, not just myocarditis and pericarditis. How many people with myocarditis from any cause end up in ICU? You can be very sick without being in ICU. Any studies on recovery of professional athletes with myocarditis? Do they return to full high performance capacity and are there any long term sequelae such as cardiac aneurysm, MI, heart failure, pulmonary hypertension? Would you ever consider myocarditis a “mild” disease? Myocarditis occurs most commonly in young males, whom we would expect to be generally fit and healthy with many years of life ahead of them. What about the cohort who die from Covid? Isn’t their average age above 80 years? Let’s analyse all these stats more objectively.

Dr Suzette Julie Finch   28/06/2022 12:33:12 PM

Dr San ; agree this is important but you have forgotten in your equation the significant risk of myocarditis from Covid-19 infection - including the young athletes (their ‘fitness’ is not really an exclusion for this well documented complication of Covid-19 infection). I also get a little irritated by the assumption that someone over the age of 65 yo has no significant right to continue living or conversely you statements that implies that older people dying with this disease is important when ‘objectively analysing the stats. I see a significant number of products non or semi retired people over 65 yo still living productive fit & functional lives (often unpaid by their young fit adult children !) Diminishing their inclusion or the immunocompromised , pregnant or (traditionally labelled) disabled individuals in the equation diminishes our society. We are talking about a multi-faceted Public health initiative not an ark! First they came for the socialists …….